The Latest Headlines at ETF Daily News
Davies Financial Advisors Inc. Sells 497 Shares of Alphabet Inc. (NASDAQ:GOOGL)
Davies Financial Advisors Inc. reduced its holdings in shares of Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 4.2% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 11,409 shares of the... More of this article »
PPG Industries, Inc. (NYSE:PPG) Shares Sold by Crossmark Global Holdings Inc.
Crossmark Global Holdings Inc. reduced its stake in shares of PPG Industries, Inc. (NYSE:PPG – Free Report) by 10.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).... More of this article »
Rezny Wealth Management Inc. Purchases 210 Shares of Alphabet Inc. (NASDAQ:GOOGL)
Rezny Wealth Management Inc. grew its position in Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 2.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned... More of this article »
Nu Holdings Ltd. (NYSE:NU) Shares Purchased by Crossmark Global Holdings Inc.
Crossmark Global Holdings Inc. increased its stake in Nu Holdings Ltd. (NYSE:NU – Free Report) by 1.9% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional... More of this article »
Crossmark Global Holdings Inc. Trims Holdings in The Hershey Company (NYSE:HSY)
Crossmark Global Holdings Inc. lowered its stake in shares of The Hershey Company (NYSE:HSY – Free Report) by 23.1% in the fourth quarter, HoldingsChannel.com reports. The firm owned 6,890 shares of the company’s stock... More of this article »
Crossmark Global Holdings Inc. Boosts Stock Holdings in Galapagos NV (NASDAQ:GLPG)
Crossmark Global Holdings Inc. boosted its position in Galapagos NV (NASDAQ:GLPG – Free Report) by 31.5% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund... More of this article »
Reliant Investment Management LLC Acquires New Shares in JPMorgan Chase & Co. (NYSE:JPM)
Reliant Investment Management LLC bought a new position in shares of JPMorgan Chase & Co. (NYSE:JPM – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities &... More of this article »
Crossmark Global Holdings Inc. Acquires New Holdings in Pilgrim’s Pride Co. (NASDAQ:PPC)
Crossmark Global Holdings Inc. bought a new position in Pilgrim’s Pride Co. (NASDAQ:PPC – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The... More of this article »
Baidu, Inc. (NASDAQ:BIDU) Holdings Lifted by Crossmark Global Holdings Inc.
Crossmark Global Holdings Inc. grew its holdings in shares of Baidu, Inc. (NASDAQ:BIDU – Free Report) by 14.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange... More of this article »
Crossmark Global Holdings Inc. Has $1.18 Million Holdings in Royal Gold, Inc. (NASDAQ:RGLD)
Crossmark Global Holdings Inc. raised its stake in shares of Royal Gold, Inc. (NASDAQ:RGLD – Free Report) (TSE:RGL) by 33.4% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 8,913 shares... More of this article »
Crossmark Global Holdings Inc. Buys 292 Shares of Comfort Systems USA, Inc. (NYSE:FIX)
Crossmark Global Holdings Inc. increased its stake in Comfort Systems USA, Inc. (NYSE:FIX – Free Report) by 10.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange... More of this article »
Ballentine Partners LLC Acquires 437 Shares of Microchip Technology Incorporated (NASDAQ:MCHP)
Ballentine Partners LLC raised its holdings in shares of Microchip Technology Incorporated (NASDAQ:MCHP – Free Report) by 10.2% in the 4th quarter, Holdings Channel.com reports. The firm owned 4,713 shares of the semiconductor... More of this article »
UroGen Pharma (NASDAQ:URGN) Earns Buy Rating from D. Boral Capital
UroGen Pharma (NASDAQ:URGN – Get Free Report)‘s stock had its “buy” rating reaffirmed by D. Boral Capital in a research note issued on Thursday,Benzinga reports. They currently have a $25.00 price objective... More of this article »-logo-1200x675.jpg?v=20240830130102&w=240&h=220&zc=2){kind=logo}